Related Experiment Video

Updated: Jul 9, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
06:31

Transuterine Fetal Tracheal Occlusion Model in Mice

Published on: February 5, 2021

[Current and future strategy in the treatment of congenital diaphragmatic hernia]

Hiroomi Okuyama1

  • 1Department of Pediatric Surgery, Osaka Medical Center for Maternal and Child Health, Izumi, Japan.

Nihon Geka Gakkai Zasshi
|December 7, 2007
PubMed

Insights

Congenital diaphragmatic hernia (CDH) severity is linked to lung hypoplasia. Fetal tracheal occlusion shows promise as a minimally invasive treatment to improve lung growth and outcomes for severe CDH cases.

Area of Science:

  • Neonatal Medicine
  • Pediatric Surgery
  • Developmental Biology

Context:

  • Congenital diaphragmatic hernia (CDH) poses significant challenges due to associated lung hypoplasia.
  • Severe CDH cases often present with cardiopulmonary insufficiency at birth, complicating immediate management.
  • Traditional treatments like extracorporeal membrane oxygenation (ECMO) have limited indications in severe cases.

Purpose:

  • To review current and emerging treatment strategies for congenital diaphragmatic hernia (CDH).
  • To highlight advancements in respiratory support and pharmacological interventions for CDH.
  • To explore the potential of fetal tracheal occlusion as a novel therapeutic approach for severe lung hypoplasia in CDH.

Summary:

  • Current CDH management focuses on minimizing lung injury with high-frequency ventilation (HFV) and utilizing vasodilators like nitric oxide to address pulmonary hypertension.
  • Extracorporeal membrane oxygenation (ECMO) indications are narrowing for severe CDH due to fatal lung hypoplasia.
  • Temporary tracheal occlusion, particularly percutaneous fetal endoluminal tracheal occlusion, is emerging as a promising method to promote fetal lung growth and improve outcomes in severe CDH.

Impact:

  • Improved understanding of CDH pathophysiology and treatment efficacy.
  • Potential for enhanced survival rates and reduced long-term morbidity in infants with severe CDH.
  • Advancement of minimally invasive fetal interventions for congenital anomalies.

More Related Videos

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs05:40

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Published on: December 22, 2023

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...